Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2525.0000 (-0.79%) ($2419.9500 - $2525.0000) on Tue. Jul. 15, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 40 | Latest Price | $2525.0000(-0.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.8% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWI(2%) EWP(2%) IWM(2%) USO(2%) | Factors Impacting CAPR price | CAPR will decline at least -1.135% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 0 () | Intraday Trend | 4.3% | | | |
|
Resistance Level | $2584.89 | 5 Day Moving Average | $2541(-0.63%) | 10 Day Moving Average | $2572.76(-1.86%) | 20 Day Moving Average | $2584.89(-2.32%) | To recent high | -7.3% | To recent low | 12.2% | Market Cap | $49.736b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |